Retrieve available abstracts of 11 articles: HTML format
Single Articles
May 2025
NUMATA K, Ono Y, Iguchi K, Uchiyama M, et al Prognostic significance of modified Glasgow Prognostic Score in patients
undergoing FOLFOXIRI plus bevacizumab therapy for advanced or metastatic
colorectal cancer.
Oncology. 2025 May 26:1-22. doi: 10.1159/000546260. PubMedAbstract available
KEMNA R, Zeeuw JM, Ziesemer KA, Ali M, et al From development to implementation: a systematic review on the current maturity
status of artificial intelligence models for patients with colorectal cancer
liver metastases.
Oncology. 2025 May 26:1-25. doi: 10.1159/000546572. PubMedAbstract available
March 2025
KIM KM, Moon WS, Ha GW, Park HS, et al Clinicopathological significance of APC mutation in patient with colorectal
cancer.
Oncology. 2025 Mar 13:1-17. doi: 10.1159/000545255. PubMedAbstract available
DOLCI M, Civettini I, Bagnoli PF, Toumi W, et al Expression of Human Endogenous Retrovirus env-gene product is a hallmark of
sidedness in operable colorectal cancer.
Oncology. 2025 Mar 11:1-16. doi: 10.1159/000543099. PubMedAbstract available
August 2024
LIANG Y, Li Y, Guo R, Zhao Y, et al Identification and initial validation of neuroendocrine differentiation as a
novel prognostic factor in stage II colorectal cancer patients.
Oncology. 2024 Aug 19. doi: 10.1159/000540936. PubMedAbstract available
DIMBERG J, Shamoun L, Af Geijerstam K, Landerholm K, et al Significance of Gene Polymorphism and Gene Expression of BACE2 in Swedish
Patients with Colorectal Cancer.
Oncology. 2024 Aug 14:1-8. doi: 10.1159/000540887. PubMedAbstract available
July 2024
ZHOU J, Nie H, Yang X, Wang F, et al Ubiquitin-specific protease 52 as a prognostic biomarker correlates with tumor
microenvironment and therapy response in colorectal cancer.
Oncology. 2024 Jul 24. doi: 10.1159/000540441. PubMedAbstract available
ERCIYESTEPE M, Selvi O, Dinc G, Ozturk AE, et al Factors affecting recurrence and survival in Stage IIA colon cancer patients.
Oncology. 2024 Jul 15. doi: 10.1159/000540334. PubMedAbstract available
June 2024
ALKAN A, Doganer GI, Tanriverdi O Serum Uric Acid Level May Be A Predictive Factor For BRAF V600E Mutation In Older
Patients With Metastatic Colorectal Cancer: An Exploratory Analysis.
Oncology. 2024 Jun 27. doi: 10.1159/000539981. PubMedAbstract available
January 2024
WU HQ, Li J, Miao JD, Li JW, et al Is Total Neoadjuvant Treatment Beneficial for Locally Advanced Rectal Cancer? A
Meta-Analysis of Randomized Controlled Trials.
Oncology. 2024;102:399-413. PubMedAbstract available
ROMERO ZOGHBI SE, Martin Martin M, Garcia JC, Valero M, et al Total Neoadjuvant Therapy Approach for the Treatment of Locally Advanced Rectal
Cancer: Where Do We Stand?
Oncology. 2024;102:646-658. PubMedAbstract available